ATE164521T1 - Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose - Google Patents

Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose

Info

Publication number
ATE164521T1
ATE164521T1 AT92905617T AT92905617T ATE164521T1 AT E164521 T1 ATE164521 T1 AT E164521T1 AT 92905617 T AT92905617 T AT 92905617T AT 92905617 T AT92905617 T AT 92905617T AT E164521 T1 ATE164521 T1 AT E164521T1
Authority
AT
Austria
Prior art keywords
growth factor
vascular stenosis
treatment
antibodies
factor antibodies
Prior art date
Application number
AT92905617T
Other languages
English (en)
Inventor
Russell Ross
Michael A Reidy
Elaine W Raines
Volkhard Lindner
Gordon A A Ferns
Christopher Jackson
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE164521T1 publication Critical patent/ATE164521T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT92905617T 1991-01-17 1992-01-17 Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose ATE164521T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64175891A 1991-01-17 1991-01-17

Publications (1)

Publication Number Publication Date
ATE164521T1 true ATE164521T1 (de) 1998-04-15

Family

ID=24573729

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97106298T ATE216592T1 (de) 1991-01-17 1992-01-17 Anti-plättchen-wachstumsfaktor-antikörper in der behandlung von restenose
AT92905617T ATE164521T1 (de) 1991-01-17 1992-01-17 Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT97106298T ATE216592T1 (de) 1991-01-17 1992-01-17 Anti-plättchen-wachstumsfaktor-antikörper in der behandlung von restenose

Country Status (10)

Country Link
US (1) US5648076A (de)
EP (2) EP0798002B1 (de)
JP (2) JP3667752B2 (de)
AT (2) ATE216592T1 (de)
AU (1) AU665529B2 (de)
CA (1) CA2100876A1 (de)
DE (2) DE69232579T2 (de)
DK (2) DK0798002T3 (de)
ES (2) ES2174144T3 (de)
WO (1) WO1992012734A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770198A (en) * 1988-05-18 1998-06-23 The Research Foundation Of The State Of New York Platelet-specific chimeric 7E3 immunoglobulin
WO1996040250A2 (en) * 1995-06-07 1996-12-19 Centocor, Inc. Platelet-specific chimeric immunoglobulin and methods of use therefor
US7241568B2 (en) 1996-04-03 2007-07-10 Kyowa Hakko Kogyo Co., Ltd. Anti-fibroblast growth factor-8 monoclonal antibody
WO1998035697A1 (en) * 1997-02-14 1998-08-20 Roche Diagnostics Gmbh Improved method for the reduction of neointima formation after angioplasty
DE60226253T2 (de) * 2001-06-28 2009-05-14 Kyowa Hakko Kogyo Co., Ltd. Humanisierter antikörper gegen fibroblastenwachstumsfaktor 8 und fragment des antikörpers
EP2060270A3 (de) * 2003-10-16 2009-12-09 Imclone LLC Fibroblasten-Wachstumsfaktorrezeptor-1-Inhibitoren und Behandlungsverfahren damit
US9339593B2 (en) * 2007-01-11 2016-05-17 Robert L. Bjork, JR. Drug-eluting coronary artery stent coated with anti-platelet-derived growth factor antibodies overlaying extracellular matrix proteins with an outer coating of anti-inflammatory (calcineurin inhibitor) and/or anti-proliferatives
US20080172124A1 (en) * 2007-01-11 2008-07-17 Robert Lamar Bjork Multiple drug-eluting coronary artery stent for percutaneous coronary artery intervention
WO2016149103A1 (en) * 2015-03-13 2016-09-22 The Regents Of The University Of California Monoclonal antibody for prevention and/or treatment of astrovirus disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0288687B1 (de) * 1987-03-03 1994-12-28 Takeda Chemical Industries, Ltd. Monoklonaler Antikörper, Hybridomen, ihre Herstellung und ihre Verwendung
AU607306B2 (en) * 1988-02-02 1991-02-28 Regents Of The University Of California, The Human platelet-derived growth factor receptor
US5268358A (en) * 1988-12-08 1993-12-07 Cor Therapeutics, Inc. PDGF receptor blocking peptides
WO1991006668A1 (en) * 1989-10-27 1991-05-16 The Du Pont Merck Pharmaceutical Company Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
JP4350370B2 (ja) * 2002-12-27 2009-10-21 株式会社半導体エネルギー研究所 電子回路及び電子機器

Also Published As

Publication number Publication date
AU1327492A (en) 1992-08-27
EP0573510B1 (de) 1998-04-01
EP0798002A1 (de) 1997-10-01
EP0573510A1 (de) 1993-12-15
DE69232579T2 (de) 2002-08-22
JPH06504551A (ja) 1994-05-26
DE69224983T2 (de) 1998-07-30
DK0798002T3 (da) 2002-08-19
ATE216592T1 (de) 2002-05-15
ES2174144T3 (es) 2002-11-01
DE69232579D1 (de) 2002-05-29
DK0573510T3 (da) 1998-04-27
JP2002316945A (ja) 2002-10-31
DE69224983D1 (de) 1998-05-07
ES2117046T3 (es) 1998-08-01
JP3667752B2 (ja) 2005-07-06
EP0798002B1 (de) 2002-04-24
US5648076A (en) 1997-07-15
AU665529B2 (en) 1996-01-11
CA2100876A1 (en) 1992-07-18
WO1992012734A1 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
SE8803472D0 (sv) Anvaendning av gamma-interferon foer behandling av vaskulaer stenos
DE69226841D1 (de) Okklusionsvorrichtung zur Reparatur von Herz- und Gefäss-Defekten
DE69206341D1 (de) Verfahren zur Behandlung von BCTMP/CTMP-Abwasser.
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
DE69224080D1 (de) Verwendung von nsaid zur behandlung von demenz
ATE164521T1 (de) Anti-wachstumsfaktor antikörper in der behandlung von gefässstenose
DE68907423D1 (de) Behandlung der akne.
NO901141L (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
DE69215885D1 (de) Behandlung von fleisch
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
DK452089D0 (da) Anvendelse af ace-inhibitorer
DE69225754D1 (de) Verfahren zur Behandlung von wasserunlöslichen Superabsorbensmaterialien
NO922531D0 (no) Middel for forhindring av og behandling av fiskesykdommer
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO924637D0 (no) Fremgangsmaate ved forhindring av gjentilstopping av arterier
DE69212119D1 (de) Behandlung von Fotoresistabfall
DE69124415D1 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
FR2669539B1 (fr) Dispositif pour la circulation artificielle du sang et transfuseur autologue de sang total.
DK417889A (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
DE69133542D1 (de) Katheter zur Behandlung von Prostaterkrankungen
IT228470Y1 (it) Catetere per la disostruzione delle arterie
NO905643L (no) Fremgangsmaate for behandling av manganslam.
IT8867135A0 (it) Protesi ad espansione endoluminale particolarmente per il trattamentodi patologie vascolari

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee